Corticosteroid Therapy in a Case of Severe Cholestasic Hepatitis Associated with Amoxicillin–Clavulanate
- 17 March 2010
- journal article
- case report
- Published by Springer Nature in Journal of Medical Toxicology
- Vol. 6 (4) , 420-423
Abstract
Amoxicillin–clavulanate is the most common drug involved in drug-induced liver injury and the single most frequently prescribed product leading to hospitalization for drug-induced liver disease in Spain. The liver damage most frequently associated with amoxicillin–clavulanate is cholestasic type. The latency period between first intake and onset of symptoms is 3–4 weeks on average. A 76-year-old man developed fever, pruritus, and jaundice 3 weeks after having completed treatment with amoxicillin–clavulanate. Liver function tests showed cholestasic hepatitis (up to 50.75 mg/dL of total serum bilirubin level). The ultrasound-guided liver biopsy revealed severe canalicular cholestasis and portal and lobular eosinophilic infiltrates. Prednisone and ursodeoxycholic acid therapy were then prescribed. The patient became symptom-free with normal liver function tests. Amoxicillin–clavulanate can cause hepatocellular, cholestasic, or mixed liver injury. The presence of eosinophilic infiltrates in the liver biopsy and the clinical signs of hypersensitivity in some of the cholestasic cases suggest a pathophysiological immunoallergic mechanism. For this reason, corticosteroid treatment should be considered for patients with severe cholestasic liver injury.Keywords
This publication has 13 references indexed in Scilit:
- Practical guidelines for diagnosis and early management of drug-induced liver injuryWorld Journal of Gastroenterology, 2008
- Antibiotic therapy: a major cause of drug-induced jaundice in southwest EnglandEuropean Journal of Gastroenterology & Hepatology, 2007
- Determinants of the clinical expression of amoxicillin‐clavulanate hepatotoxicityHepatology, 2006
- Steroid Therapy for a Case of Severe Drug-Induced CholestasisAnnals of Pharmacotherapy, 2006
- Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year PeriodGastroenterology, 2005
- Acute and clinically relevant drug‐induced liver injury: a population based case‐control studyBritish Journal of Clinical Pharmacology, 2004
- Co-amoxiclav jaundice: clinical and histological features and HLA class II associationGut, 2000
- Ursodeoxycholic acid (UDCA) for the treatment of amoxycillin-clavulanate potassium (Augmentin®)-induced intra-hepatic cholestasisEuropean Journal of Gastroenterology & Hepatology, 2000
- Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuriesJournal of Clinical Epidemiology, 1993
- Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases.Gut, 1992